- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 46
Investors deliver $2.5m to AmacaThera
Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.
Jan 14, 2019Repsol wraps up Nanogap investment
Nanomaterials provider Nanogap, a spinout of University of Santiago de Compostela, received $2.1m from Repsol's Corporate Venture vehicle.
Jan 14, 2019Lettus Grow harvests $585,000
University of Bristol Enterprise Fund has returned with more cash for irrigation system developer Lettus Grow, founded by Bristol graduates and students.
Jan 11, 2019IU fund pours $500,000 into Diagnotes
Indiana University Philanthropic Venture Fund has joined Purdue Ventures and university-backed VC vehicle Indiana Seed Fund as an investor in healthcare communication platform Diagnotes.
Jan 10, 2019PetaGene generates $2.1m
PetaGene hopes its data compression technology will aid the genomic sequencing industry.
Jan 9, 2019NUI Galway companies garner $40m in 2018
NUI Galway-linked businesses to have secured backing last year include kidney reflux test spinout Kite Medical and medical implant developer Loci Orthopaedics.
Jan 9, 2019Atriva finds series A relief
Spun out of Tübingen, Justus Liebig University Gießen and Münster, Atriva Therapeutics has raised an initial $1.4m to progress next-generation antiviral drugs for conditions including influenza.
Jan 8, 2019Exonate spots $1.9m round
Based on research from the universities of Bristol and Nottingham, Exonate has now raised $9m to develop a topical eye drop for conditions including diabetic macular edema.
Jan 7, 2019Shimane ships in $1.9m for nanotech
The funding for Shimane's Nanotechnology Project Center came from San-in Godo Bank through an industry-academia cooperation program.
Jan 4, 2019PreOmics sheds light on $3.8m series A
HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.
Jan 4, 2019
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.